… Binding of SARS-CoV-2 spike protein to human angiotensin-converting enzyme 2 (hACE2) …
models to study SARS-CoV-2 infection, molecular pathways involved in SARS-CoV-2-…

… rigor in scientific evaluation and expediency in developing therapies that help to slow down
the … the nature of SARS-CoV-2, though we now know much more about SARS-CoV-2 and the …

… antiviral effects in treating SARS coronavirus infection. It is noteworthy that no research
has reported tracing any cytopathogenic effects of CTS alone in treating the SARS virus [Citation…

… therapy thus became an emergency. This report aims to highlight Resveratrol as possible
therapeutic candidate in SARS-CoV… for several viruses, including coronavirus. Resveratrol was …

… life cycle and pathogenesis of SARS-CoV will help us to develop vaccines and therapeutics
to prevent and treat SARS-CoV and SARS-like coronavirus (SL-CoV) infections in the future. …

… therapeutic intervention point. In this regard, this review will focus on the therapeutic targeting
of the crucial steps of SARS-CoV-2 … on several therapeutic opportunities, pharmacological …

… main therapeutic strategies against COVID-19, namely drugs targeting the SARS-CoV-2 life
cycle and SARS-CoV-2-… Considering the emerging SARS-CoV-2 variants greatly impact the …

… Undoubtedly, future efforts to deepen our understanding of the molecular mechanisms of
SARS-CoV-2 will provide opportunities to develop more effective and promising therapeutics. …

… SARS-CoV-2 is the third coronavirus causing severe infection in humans after severe acute
respiratory syndrome coronavirus (SARS-CoV-1) … for anti-SARS CoV-2 agent development. …

… therapy used against SARS-CoV-2. The review also summarizes the data recorded on the
mechanism of anti-SARS-CoV-… and clinical findings, therapeutic regimens, pharmacokinetics, …